Abstract
Objectives
The aim of the current study is to evaluate the differences in the rate of perinatal group B streptococcal vertical transmission between women who correctly underwent the CDC 2002 guidelines and women who did not.
Methods
Two study groups: women who correctly underwent the CDC 2002 guidelines (study group 1) and women who did not (study group 2). Intrapartum chemoprophylaxis (IC) was administered to all pregnant women identified as GBS carrier. All newborns received, in the first hour of life, a culture based screening for GBS colonization.
Results
One thousand six hundred and sixty nine women were enrolled in the study. The 2002 CDC guidelines were correctly applied in 1273 (76.3%) subjects. There was no early-onset GBS disease. No statistically significant difference in the total number of colonized newborns between study group 1 (4.1%) and study group 2 (3.3%) was found. When the analysis was limited to women with positive GBS screening, a significant difference (P < 0.001) was observed in the number of colonized newborns between mothers who received IC during at least 4 h (group 1; 3.7%) and those who received an IC during less than 4 h (group 1; 12.3%).
Conclusion
The accurate application of the 2002 CDC guidelines is strongly supported but, to furthermore reduce the risk for GBS colonization and sepsis in the newborns, it appears desirable to identify additional and new prevention strategies.
Similar content being viewed by others
Abbreviations
- AAP:
-
American Academy of Pediatrics
- ACOG:
-
American College of Obstetricians and Gynecologists
- CDC:
-
Centers for Disease Control and Prevention
- EOGBS:
-
Early-onset group B Streptococcus disease
- g:
-
Gram
- GBS:
-
Group B Streptococcus
- IC:
-
Intrapartum chemoprophylaxis
- mg:
-
Milligram
- ml:
-
Milliliter
- n:
-
Number
- μg:
-
Microgram
References
Eickoff TC, Klein JO, Daly AK, Ingall D, Finland M (1964) Neonatal sepsis and other infections due to group B beta-hemolytic streptococci. N Engl J Med 271:1221–1228
Schrag SJ, Zell ER, Lynfield R et al (2002) A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates. N Engl J Med 347:233–239
Davies H, LeBlanc J, Bortolussi R, McGeer A (1999) The pediatric investigators collaborative network on infections in Canada (PICNIC) study of neonatal group B streptococcal infections in Canada. Pediatr Child Health 4:257–263
Davies HD, Raj S, Adair C, Robinson J, McGeer A (2001) Population-based active surveillance for neonatal group B streptococcal infections in Alberta, Canada: implications for vaccine formulation. Pediatr Infect Dis J 20:879–884
Schuchat A (1998) Epidemiology of group B streptococcal disease in tha United States: shifting paradigm. Clin Microbiol Rev 11:497–513
Schuchat A (1999) Group B streptococcus. Lancet 353:51–56
Schrag SJ, Zywicki S, Farley MM, Reingold AL, Harrison LH, Lefkowitz LB et al (2000) Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med 342:15–20
American Academy of Pediatrics (1997) Revised guidelines for prevention of early-onset group B streptococcal (GBS) infection. Pediatrics 99:489–496
Hall RT, Barnes W, Krishan L, Harris DJ, Rhodes PG, Fayez J, et al (1976) Antibiotic treatment of parturient women colonized with group B streptococci. Am J Obstet Gynecol 124:630–634
Gardner SE, Yow MD, Leeds LJ, Thompson PK, Mason EO Jr, Clark DJ (1979) Failure of penicillin to eradicate group B streptococcal colonization in the pregnant women: a couple study. Am J Obstet Gynecol 135:1062–1065
Committee on Obstetric Practice (1996) American College of Obstetricians and Gynecologists. Prevention of early-onset group B streptococcal disease in newborns: ACOG Committee Opinion No. 173. Washington, ACOG
Schrag SJ, Zell ER, Lynfield R, Roome A, Arnold KE, Craig AS, Harrison LH, Reingold A, Stefonek K, Smith G, Gamble M, Schuchat A (2002) A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates. N Engl J Med 347:233–239
Prevention of perinatal group B streptococcal disease (2002) Revised guidelines from CDC. MMWR Recomm Rep 51(RR-11):1–22
Prevention of early-onset group B streptococcal disease in newborns (2002) ACOG Committee Opinion No. 279. American College of Obstetricians and Gynecologists. Obstet Gynecol 100:1405–1412
Gilbert GL, Hewitt MC, Turner CM, Leeder SR (2002) Epidemiology and predictive values of risk factor for neonatal group B streptococcal sepsis. Aust NZ J Obstet Gynaecol 42:497–503
Sweet RL, Gibbs RS (2002) Group B Streptococci. In: Sweet RL, Gibb RS (eds) Infectious diseases of the female genital tract, 4th edn. Lippincott Williams & Wilkins, Philadelphia, pp 31–46
Nemunaitis-Keller J, Gill P (2003) Limititations of the obstetric group B Streptococcus protocol. J Reprod Med 48(2):107–111
Chandran L, Navaie-Waliser M, Zulqarni NJ, Batra S, Bayir H, Shah M, Lincoln PP (2001) Compliance with group B streptococcal disease prevention guidelines. MCN Am J Matern Child Nurs 26(6):313–319
Simoes JA, Aroutcheva AA, Heimler I, Faro S (2004) Antibiotic resistance patterns of group B streptococcal clinical isolates. Infect Dis Obstet Gynecol 12:1–8
Rouse DJ, Andrews WW, Lin FC et al (1998) Antibiotic susceptibility profile of GBS acquired vertically. Obstet Gynecol 92:931–934
Betriu C, Gomez M, Sanchez A et al (1994) Antibiotic resistance and penicillin tolerance in clinical isolates of GBS. Antimicrob Agents Chemother 38:2183–2186
Liu JW, Wu JJ, Ko WC, Chuang YC (1997) Clinical characteristics and antimicrobial susceptibility of invasive GBS infection in non pregnant adults in Taiwan. J Formos Med Assoc 96:628–633
Levine EM, Ghai V, Barton JJ, Strom CM (1999) Intrapartum antibiotic prophylaxis increases the incidence of Gram-negative neonatal sepsis. Infect Dis Obstet Gynecol 7:210–213
Mercier BM, Carr TL, Beazley DD, Crouse DT, Sibai BM (1999) Antibiotic use in pregnancy and drug-resistant infant sepsis. Am J Obstet Gynecol 181:816–821
The International Collaborative Study of Severe Anaphylaxis (2003) Risk of anaphylaxis in a hospital population in relation to the use of various drugs: an international study. Pharmacoepidemiol Drug Saf 12:195–202
Neugut AI, Ghatak AT, Miller RL (2001) Anaphylaxis in the United States: an investigation into its epidemiology. Arch Intern Med 161:15–21
Dunn AB, Blomquist J, Khouzami V (1999) Anaphylaxis in labor secondary to prophylaxis against group B Streptococcus. A case report. J Reprod Med 44:381–384
Miller EL (2002) The penicillins: a review and update. J Midwifery Womens Health 47:426–434
Davies HD, Miller MA, Faro S, Gregson D, Kehl SC, Jordan JA (2004) Multicenter study of a rapid molecular-based assay for the diagnosis of group B Streptococcus colonization in pregnant women. Clin Infect Dis 39:1129–1135
Sinha A, Lieu TA, Paoletti LC, Weinstein MC, Platt R (2005) The projected health benefits of maternal group B streptococcal vaccination in the era of chemoprophylaxis. Vaccine 23:3187–3195
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lijoi, D., Capua, E.D., Ferrero, S. et al. The efficacy of 2002 CDC guidelines in preventing perinatal group B Streptococcal vertical transmission: a prospective study. Arch Gynecol Obstet 275, 373–379 (2007). https://doi.org/10.1007/s00404-006-0263-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-006-0263-7